Publications by authors named "Dale Ando"

Claim this Profile
C
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
Pablo Tebas, Julie K Jadlowsky, Pamela A Shaw, Lifeng Tian, Erin Esparza, Dale Ando

J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
Pablo Tebas, Julie K Jadlowsky, Pamela A Shaw, Lifeng Tian, Erin Esparza, Dale Ando

J Clin Invest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CERE-120 Prevents Irradiation-Induced Hypofunction and Restores Immune Homeostasis in Porcine Salivary Glands.
Isabelle M A Lombaert, Vaishali N Patel, Christina E Jones, Derrick C Villier, Ashley E Canada, Dale Ando

Mol Ther Methods Clin Dev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Editing: Regulatory and Translation to Clinic.
Dale Ando, Kathleen Meyer

Hematol Oncol Clin North Am· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.
Gaia Skibinski, Vicky Hwang, Dale Michael Ando, Aaron Daub, Alicia K Lee

Proc Natl Acad Sci U S A· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking the Regulatory Infrastructure for Human Gene Transfer Clinical Trials.
Christopher L Jenkins, Mark L Bagarazzi, Hans-Peter Kiem, Arnold J Levine, Dale Ando

Mol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.
Joal D Beane, Gary Lee, Zhili Zheng, Matthew Mendel, Daniel Abate-Daga, Dale Ando

Mol Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.
Sarah A Figley, Yang Liu, Spyridon K Karadimas, Kajana Satkunendrarajah, Peter Fettes, Dale Ando

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
Pablo Tebas, David Stein, Winson W Tang, Ian Frank, Shelley Q Wang, Dale G Ando

N Engl J Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
Dawn A Maier, Andrea L Brennan, Shuguang Jiang, Gwendolyn K Binder-Scholl, Gary Lee, Dale Ando

Hum Gene Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.
Andrea Serio, Bilada Bilican, Sami J Barmada, Dale Michael Ando, Chen Zhao

Proc Natl Acad Sci U S A· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A.
Ishita Siddiq, Eugene Park, Elaine Liu, S Kaye Spratt, Richard Surosky, Dale Ando

J Neurotrauma· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A.
Philippe M D'Onofrio, Mahinthan Thayapararajah, Meghan D Lysko, Mark Magharious, S Kaye Spratt, Dale Ando

J Neurotrauma· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury.
Yang Liu, Sarah Figley, S Kaye Spratt, Gary Lee, Dale Ando

Neurobiol Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.
Elena E Perez, Jianbin Wang, Jeffrey C Miller, Yann Jouvenot, Kenneth A Kim, Dale Ando

Nat Biotechnol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.
Angelo Lombardo, Pietro Genovese, Christian M Beausejour, Silvia Colleoni, Ya-Li Lee, Dale Ando

Nat Biotechnol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
Eric J Small, Natalie Sacks, John Nemunaitis, Walter J Urba, Eugene Dula, Dale Ando

Clin Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.
Eric J Small, Michael A Carducci, James M Burke, Ron Rodriguez, Lawrence Fong, Dale Ando

Mol Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
Jonathan W Simons, Michael A Carducci, Bahar Mikhak, Michael Lim, Barbara Biedrzycki, Dale G Ando

Clin Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings.
Kenzaburo Tani, Miyuki Azuma, Yukoh Nakazaki, Naoki Oyaizu, Hidenori Hase, Dale Ando

Mol Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider.
Richard Vile, Dale Ando, David Kirn

Cancer Gene Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectively replicating oncolytic adenoviruses as cancer therapeutics.
De-Chao Yu, Peter Working, Dale Ando

Curr Opin Mol Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced renal cell carcinoma treated with granulocyte-macrophage colony-stimulating factor gene therapy: a clinical course of the first Japanese experience.
Koji Kawai, Kenzaburo Tani, Naohide Yamashita, Shinji Tomikawa, Masazumi Eriguchi, Dale Ando

Int J Urol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy and molecular immunology unite to give new life to cancer immunotherapy.
Dale Ando

Mol Ther· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis